Balchem Corp. Announces 2024 Annual Meeting of Shareholders on June 20, 2024

Ticker: BCPC · Form: DEF 14A · Filed: Apr 26, 2024 · CIK: 9326

Balchem CORP DEF 14A Filing Summary
FieldDetail
CompanyBalchem CORP (BCPC)
Form TypeDEF 14A
Filed DateApr 26, 2024
Risk Levellow
Pages15
Reading Time19 min
Sentimentneutral

Sentiment: neutral

Topics: Annual Meeting, Proxy Statement, Shareholder Vote, Corporate Governance, Executive Compensation

TL;DR

<b>Balchem Corporation will host its 2024 Annual Meeting of Shareholders virtually on June 20, 2024, with key agenda items including director elections, auditor ratification, and executive compensation approval.</b>

AI Summary

BALCHEM CORP (BCPC) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Balchem Corporation will hold its 2024 Annual Meeting of Shareholders virtually on June 20, 2024, at 9:00 a.m. EDT. Shareholders can attend, listen, vote, and submit questions online via webcast at www.virtualshareholdermeeting.com/BCPC2024. The meeting agenda includes the election of four Class 2 directors, ratification of RSM US LLP as independent auditors for FY2024, and advisory approval of executive compensation ('Say-on-Pay'). Shareholders are strongly encouraged to read the 2024 Proxy Statement and Notice of Annual Meeting for important information on corporate governance and executive compensation. Proxy voting instructions are available via Internet, telephone, or mail, and are detailed in the Notice of Internet Availability of Proxy Materials and on page 67 of the Proxy Statement.

Why It Matters

For investors and stakeholders tracking BALCHEM CORP, this filing contains several important signals. The virtual format allows for broader shareholder participation and accessibility, enabling remote voting and question submission. The meeting's agenda covers critical governance and financial oversight matters, including board composition and auditor independence, requiring shareholder input.

Risk Assessment

Risk Level: low — BALCHEM CORP shows low risk based on this filing. The filing is a routine proxy statement for an annual shareholder meeting, with no immediate financial or operational disclosures that would indicate high risk.

Analyst Insight

Shareholders should review the proxy materials to understand director nominees, executive compensation, and auditor ratification before voting.

Key Numbers

Key Players & Entities

FAQ

When did BALCHEM CORP file this DEF 14A?

BALCHEM CORP filed this Proxy Statement (DEF 14A) with the SEC on April 26, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by BALCHEM CORP (BCPC).

Where can I read the original DEF 14A filing from BALCHEM CORP?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by BALCHEM CORP.

What are the key takeaways from BALCHEM CORP's DEF 14A?

BALCHEM CORP filed this DEF 14A on April 26, 2024. Key takeaways: Balchem Corporation will hold its 2024 Annual Meeting of Shareholders virtually on June 20, 2024, at 9:00 a.m. EDT.. Shareholders can attend, listen, vote, and submit questions online via webcast at www.virtualshareholdermeeting.com/BCPC2024.. The meeting agenda includes the election of four Class 2 directors, ratification of RSM US LLP as independent auditors for FY2024, and advisory approval of executive compensation ('Say-on-Pay')..

Is BALCHEM CORP a risky investment based on this filing?

Based on this DEF 14A, BALCHEM CORP presents a relatively low-risk profile. The filing is a routine proxy statement for an annual shareholder meeting, with no immediate financial or operational disclosures that would indicate high risk.

What should investors do after reading BALCHEM CORP's DEF 14A?

Shareholders should review the proxy materials to understand director nominees, executive compensation, and auditor ratification before voting. The overall sentiment from this filing is neutral.

How does BALCHEM CORP compare to its industry peers?

Balchem Corporation operates in the chemical industry, providing specialty ingredients for nutrition and health markets.

Are there regulatory concerns for BALCHEM CORP?

The filing is a proxy statement (DEF 14A) filed under the Securities Exchange Act of 1934, requiring specific disclosures for shareholder meetings.

Industry Context

Balchem Corporation operates in the chemical industry, providing specialty ingredients for nutrition and health markets.

Regulatory Implications

The filing is a proxy statement (DEF 14A) filed under the Securities Exchange Act of 1934, requiring specific disclosures for shareholder meetings.

What Investors Should Do

  1. Review the proxy statement for details on director nominees and their qualifications.
  2. Understand the 'Say-on-Pay' proposal regarding executive compensation.
  3. Confirm the ratification of RSM US LLP as the independent auditor for fiscal year 2024.

Key Dates

Year-Over-Year Comparison

This is the initial filing for the 2024 proxy statement, providing details for the upcoming annual shareholder meeting.

Filing Stats: 4,634 words · 19 min read · ~15 pages · Grade level 13.9 · Accepted 2024-04-26 16:20:28

Filing Documents

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 46 Summary Compensation Table 46 2023 Grants of Plan-Based Awards 48 Terms and Conditions of Awards 49 Outstanding Equity Awards at Fiscal Year End 2023 50 Option Exercises and Stock Vested in 2023 51 Nonqualified Deferred Compensation 52 Termination of Employment and Change in Control Arrangements 52 Related Party Transactions 54 Equity Compensation Plan Information 55 CEO Pay Ratio 56 Pay versus Performance Disclosure 57

Security Ownership of Certain Beneficial

Security Ownership of Certain Beneficial 61 Delinquent Section 16(a) Reports 63 INFORMATION RELATING TO PROPOSAL 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 64 Audit Committee Report 64 MISCELLANEOUS ITEMS 66 Quorum Required 66 Voting Securities 66 Shareholder Proposals for 2025 Annual Meeting of Shareholders 66 Director Attendance at Annual Meetings of Shareholders 66 Matters Not Determined at the Time of Solicitation 66 Instructions for the Virtual Annual Meeting 67 APPENDIX A - NON-GAAP FINANCIAL MEASURES A-1 2 TABLE OF CONTENTS Notice of Annual Meeting of SHAREHOLDERS for Balchem Corporation DATE AND TIME: Thursday, June 20, 2024, 9:00 a.m., Eastern Daylight Time (" EDT ") PLACE: Online, at www.virtualshareholdermeeting.com/BCPC2024 ITEMS OF BUSINESS: 1. Election of four Class 2 director nominees to the Board of Directors of Balchem Corporation (" Balchem " or the " Company ") to serve until the 2027 Annual Meeting of Shareholders and until their successors are duly elected and qualified; 2. Ratification of the appointment of RSM US LLP (" RSM ") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024; 3. Advisory approval of the compensation of the Company's named executive officers (" Say-on-Pay "); and 4. To transact such other business as may properly come before the 2024 Annual Meeting of Shareholders (the " Annual Meeting ") or any postponement or adjournment thereof. WHO CAN VOTE: Shareholders of record at the close of business on April 22, 2024. HOW TO VOTE: Shareholders who receive a printed copy of this Proxy Statement and who do not expect to attend the Meeting are requested to complete, date and sign the enclosed Proxy Card and promptly return the same in the stamped, self-addressed envelope enclosed for your convenience. Shareholders may also submit a Proxy Card

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing